Last reviewed · How we verify
r-hFSH and r-hLH — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
r-hFSH and r-hLH (r-hFSH and r-hLH) — Reproductive Medicine Associates of New Jersey.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| r-hFSH and r-hLH TARGET | r-hFSH and r-hLH | Reproductive Medicine Associates of New Jersey | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- r-hFSH and r-hLH CI watch — RSS
- r-hFSH and r-hLH CI watch — Atom
- r-hFSH and r-hLH CI watch — JSON
- r-hFSH and r-hLH alone — RSS
Cite this brief
Drug Landscape (2026). r-hFSH and r-hLH — Competitive Intelligence Brief. https://druglandscape.com/ci/r-hfsh-and-r-hlh. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab